课题基金 / 基金详情

Replication and secretion of hepatitis B virus variants

Replication and secretion of hepatitis B virus variants
乙型肝炎病毒变异体的复制和分泌
批准号:
6557207
负责人:
SHUPING TONG
金额:
$15.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2005-04-30

项目摘要

项目成果

SHUPING TONG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):乙肝病毒(乙肝病毒)感染全球4亿人,并导致肝炎、肝硬变和肝癌。乙肝病毒相关的肝病是病毒与宿主之间复杂相互作用的结果。核心启动子突变株是普遍存在的HBeAg表达降低的变异株,在HBe感染晚期和抗HBe阶段取代野生型株。这些突变被认为与暴发性肝炎有关。核心启动子突变体的复制能力仍然存在争议。目前的方法将最常见的1762/1764位核心启动子突变引入到野生型乙肝病毒基因组中,因此在省略基因组其他地方的其他核心启动子突变和共同进化突变方面存在缺陷。我们方法的新颖性是测试自然发生的核心启动子突变是否比野生型菌株复制更有效。我们已经鉴定出两个核心启动子突变体(4B和3.4),它们的复制水平分别是野生型分离物的10倍和5倍。两者均含有1762/1764和额外突变(S)。4B分泌病毒颗粒培养上清液的效率是3.4的4倍。此外,4B可分泌包膜病毒颗粒和裸核颗粒,3.4株不能分泌包膜颗粒。本研究计划进一步鉴定自然发生的核心启动子突变体的复制和分泌表型。首先,我们将研究自然发生的核心启动子突变体的复制能力。我们计划确定高复制能力是否是自然发生的核心启动子突变的共同特征。负责增强4B复制的序列将通过具有低复制克隆的嵌合构建物来缩小。在另一种方法中,将直接验证核心启动子突变对高复制表型的贡献。其次,将确定3.4和4B不同分泌表型的机制。负责的序列元件将由3.4和4B之间的镶嵌结构映射。改变的分泌是由不同的表面蛋白还是核心蛋白介导的,将被确定。这里研究的病毒复制和分泌是病毒的基本特征,对疾病严重程度、治疗反应和康复有深远影响。复制的增加和分泌的减少可能会导致包括重型肝炎在内的严重肝病。
英文摘要
DESCRIPTION (provided by applicant): Hepatitis B virus (HBV) infects 400 million people worldwide and causes hepatitis, cirrhosis, and liver cancer. HBV related liver diseases are the outcome of complex interplay between the virus and its host. Core promoter mutants are prevalent HBV variants with reduced HBeAg expression, which replace the wildtype strains in the late HBe and anti-HBe stages of infection. Such mutants have been implicated in fulminant hepatitis. The replication capacity of core promoter mutants remains controversial. The current approach introduces the most common core promoter mutations at 1762/1764 into wild-type HBV genome, and is thus flawed in omitting other core promoter mutations and co-evolved mutations elsewhere in the genome. The novelty of our approach is to test whether naturally occurring core promoter mutants replicate more efficiently than wild-type strains. We have identified two core promoter mutants (4B and 3.4) that replicated at 10 and 5 fold higher levels than wild-type isolates, respectively. Both harbored 1762/1764 and additional mutation(s). 4B secreted viral particles to culture supernatant at 4 times higher efficiency than 3.4. Moreover, 4B secreted both enveloped viral particles and naked core particles while 3.4 failed to secrete enveloped particles. The present study plans to further characterize the replication and secretion phenotypes of naturally occurring core promoter mutants. First, we will study the replication capacity of naturally occurring core promoter mutants. We plan to establish whether high replication capacity is a common feature of naturally occurring core promoter mutants. The sequence responsible for enhanced replication of 4B will be narrowed down by chimeric constructs with a low replicating clone. In a separate approach, the contribution of core promoter mutations to the high replication phenotype will be verified directly. Second, the mechanism for different secretion phenotypes of 3.4 versus 4B will be determined. The responsible sequence element will be mapped by mosaic constructs between 3.4 and 4B. Whether altered secretion is mediated by variant surface or core protein will be determined. The viral replication and secretion as studied here are basic features of the virus with profound effect on disease severity, response to therapy and recovery. Increase in replication and decrease in secretion may help induce severe liver diseases including fulminant hepatitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Explore furin as an antiviral target to block hepatitis B virus e antigen production
  • 批准号:
    10352854
  • 项目类别:
  • 资助金额:
    $24.59万
  • 财政年份:
    2021
  • 负责人:
    SHUPING TONG
  • 依托单位:
Explore furin as an antiviral target to block hepatitis B virus e antigen production
  • 批准号:
    10495261
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2021
  • 负责人:
    SHUPING TONG
  • 依托单位:
Hepatitis B virus transcriptional interference and liver cancer-related mutations
  • 批准号:
    9089897
  • 项目类别:
  • 资助金额:
    $24.15万
  • 财政年份:
    2015
  • 负责人:
    SHUPING TONG
  • 依托单位:
Hepatitis B virus transcriptional interference and liver cancer-related mutations
  • 批准号:
    8969082
  • 项目类别:
  • 资助金额:
    $20.13万
  • 财政年份:
    2015
  • 负责人:
    SHUPING TONG
  • 依托单位:
海外基金